These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25045817)

  • 1. Development of an HIV vaccine attitudes scale to predict HIV vaccine acceptability among vulnerable populations: L.A. VOICES.
    Lee SJ; Newman PA; Duan N; Cunningham WE
    Vaccine; 2014 Sep; 32(39):5013-8. PubMed ID: 25045817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES).
    Newman PA; Lee SJ; Duan N; Rudy E; Nakazono TK; Boscardin J; Kakinami L; Shoptaw S; Diamant A; Cunningham WE
    Health Serv Res; 2009 Dec; 44(6):2167-79. PubMed ID: 19780857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endorsement of compulsory HIV vaccination policy among populations at high risk of HIV exposure (LA VOICES).
    Newman PA; Lee SJ; Rudy ET; Diamant A; Duan N; Nakazono T; Cunningham WE
    Prev Sci; 2014 Jun; 15(3):428-35. PubMed ID: 24464325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics.
    Newman PA; Duan N; Lee SJ; Rudy ET; Seiden DS; Kakinami L; Cunningham WE
    Vaccine; 2006 Mar; 24(12):2094-101. PubMed ID: 16332402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in HIV vaccine acceptability between genders.
    Kakinami L; Newman PA; Lee SJ; Duan N
    AIDS Care; 2008 May; 20(5):542-6. PubMed ID: 18484322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study.
    Connochie D; Tingler RC; Bauermeister JA
    Vaccine; 2019 Oct; 37(43):6494-6499. PubMed ID: 31522806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV vaccine acceptability among immigrant Thai residents in Los Angeles: a mixed-method approach.
    Lee SJ; Brooks RA; Newman PA; Seiden D; Sangthong R; Duan N
    AIDS Care; 2008 Nov; 20(10):1161-8. PubMed ID: 18608068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What can HIV vaccine trials teach us about future HIV vaccine dissemination?
    Newman PA; Duan N; Kakinami L; Roberts K
    Vaccine; 2008 May; 26(20):2528-36. PubMed ID: 18420313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of a Future HIV Vaccine: A Rapid Scoping Review.
    Choi J; May SB; Dang BN; Markham C; McGlone M; Cuccaro PM
    J Acquir Immune Defic Syndr; 2024 Jul; 96(3):197-207. PubMed ID: 38905472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using surrogate vaccines to assess feasibility and acceptability of future HIV vaccine trials in men: a randomised trial in inner-city Johannesburg, South Africa.
    Chimoyi L; Kamndaya M; Venables E; von Knorring N; Stadler J; MacPhail C; Chersich MF; Rees H; Delany-Moretlwe S
    BMC Public Health; 2017 Jul; 17(Suppl 3):524. PubMed ID: 28832280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV vaccine trial preparedness among Spanish-speaking Latinos in the US.
    Brooks RA; Newman PA; Duan N; Ortiz DJ
    AIDS Care; 2007 Jan; 19(1):52-8. PubMed ID: 17129857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study.
    Young AM; DiClemente RJ; Halgin DS; Sterk CE; Havens JR
    BMC Public Health; 2014 May; 14():537. PubMed ID: 24885970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV vaccine acceptability among women at risk: perceived barriers and facilitators to future HIV vaccine uptake.
    Rudy ET; Newman PA; Duan N; Kelly EM; Roberts KJ; Seiden DS
    AIDS Educ Prev; 2005 Jun; 17(3):253-67. PubMed ID: 16006211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey.
    Starace F; Wagner TM; Luzi AM; Cafaro L; Gallo P; Rezza G
    AIDS Care; 2006 Jan; 18(1):66-72. PubMed ID: 16282079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using hepatitis A and B vaccination as a paradigm for effective HIV vaccine delivery.
    Rhodes SD; Yee LJ
    Sex Health; 2007 Jun; 4(2):121-7. PubMed ID: 17524290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV vaccination acceptability among men who have sex with men in Urumqi, China.
    Tian T; Wang D; Papamichael C; Yan Z; Guoyao S; Zhanlin Z; Mahan Y; Xiaoqing T; Zheng G; Jianghong D
    Hum Vaccin Immunother; 2019; 15(4):1005-1012. PubMed ID: 30230946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 risk and vaccine acceptability in the Ugandan military.
    Hom DL; Johnson JL; Mugyenyi P; Byaruhanga R; Kityo C; Louglin A; Svilar GM; Vjecha M; Mugerwa RD; Ellner JJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug; 15(5):375-80. PubMed ID: 9342258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness to participate in HIV vaccine trials: the impact of trial attributes.
    Newman PA; Duan N; Lee SJ; Rudy E; Seiden D; Kakinami L; Cunningham W
    Prev Med; 2007 Jun; 44(6):554-7. PubMed ID: 17275895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand.
    Newman PA; Roungprakhon S; Tepjan S; Yim S
    Vaccine; 2010 Jan; 28(4):958-64. PubMed ID: 19925897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.